Brain derived versican V2 is a potent inhibitor of axonal growth

Journal of Cell Science

Volumn 113, Issue 5, 2000, Pages 807-816

  Schmalfeldt, Michael ^a   Bandtlow, Christine E ^a   Dours Zimmermann, María T ^a   Winterhalter, Kaspar H ^b   Zimmermann, Dieter R ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Axonal growth; Hyalectan; Inhibitor; Proteoglycan; Versican

Indexed keywords

ASPARAGINE LINKED OLIGOSACCHARIDE; CHONDROITIN SULFATE; OLIGOSACCHARIDE; VERSICAN;

ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE FIBER GROWTH; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; AXONS; BRAIN; CATTLE; GROWTH INHIBITORS; LECTINS, C-TYPE; MICE; NEURAL INHIBITION; NEURITES; PROTEOCHONDROITIN SULFATES; VERSICANS;

ANIMALIA;

EID: 0034077196     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Aspberg, A., Miura, R., Bourdoulous, S., Shimonaka, M., Heinegård, D., Schachner, M., Ruoslahti, E. and Yamaguchi, Y. (1997). The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc. Nat. Acad. Sci. USA 94, 10116-10121.
2. Bandtlow, C. E. and Zimmermann, D. R. (2000). Proteoglycans in the developing brain - new conceptual insights for old proteins. Physiol. Rev. 80, in press.
3. Bode-Lesniewska, B., Dours-Zimmermann, M. T., Odermatt, B. F., Briner, J., Heitz, P. U. and Zimmermann, D. R. (1996). Distribution of the large aggregating proteoglycan versican in adult human tissues. J. Histochem. Cytochem. 44, 303-312.
4. Bronner-Fraser, M. (1994). Neural crest cell formation and migration in the developing embryo. FASEB J 8, 699-706.
5. Cook, G., Tannahill, D. and Keynes, R. (1998). Axon guidance to and from choice points. Curr. Opin. Neurobiol. 8, 64-72.
6. Doege, K., Sasaki, M., Horigan, E., Hassell, J. R. and Yamada, Y. (1987). Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. J. Biol. Chem. 262, 17757-17767.
7. Dou, C. L. and Levine, J. M. (1994). Inhibition of neunte growth by the NG2 chondroitin sulfate proteoglycan. J. Neurosci. 14, 7616-7628.
8. Dours-Zimmermann, M. T. and Zimmermann, D. R. (1994). A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J. Biol. Chem. 269, 32992-32998.
9. Eggli, P. S. and Graber, W. (1996). Ultrastructural association of hyaluronan with rat unmyelinated nerve fibres. J. Neurocytol. 25, 79-87.
10. Eggli, P. S., Lucocq, J., Ott, P., Graber, W. and van der Zypen, E. (1992). Ultrastructural localization of hyaluronan in myelin sheaths of the rat central and rat and human peripheral nervous systems using hyaluronan-binding protein-gold and link protein-gold. Neuroscience 48, 737-744.
11. Fitch, M. T. and Silver, J. (1997). Glial cell extracellular matrix: boundaries for axon growth in development and regeneration. Cell Tissue Res. 290, 379-384.
12. Flanagan, J. G. and Vanderhaeghen, P. (1998). The ephrins and Eph receptors in neural development. Annu. Rev. Neurosc. 21, 309-345.
13. Friedlander, D. R., Milev, P., Karthikeyan, L., Margolis, R. K., Margolis, R. U. and Grumet, M. (1994). The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/Ll/NILE and N-CAM, and inhibits neuronal adhesion and neunte outgrowth. J. Cell Biol. 125, 669-680.
14. Hockfield, S., Kalb, R. G., Zaremba, S. and Fryer, H. (1990). Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harb. Symp. Quant. Biol. 55, 505-514.
15. Holt, C. E. and Harris, W. A. (1998). Target selection: invasion, mapping and cell choice. Curr. Opin. Neurobiol. 8, 98-105.
16. Hynes, R. O. and Lander, A. D. (1992). Contact and adhesive specificities in the associations, migrations, and targeting of cells and axons. Cell 68, 303-322.
17. Iozzo, R. (1998). Matrix proteoglycans: from molecular design to cellular function. Anna. Rev. Biochem. 67, 609-652.
18. Ito, K., Shinomura, T., Zako, M., Ujita, M. and Kimata, K. (1995). Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol. Chem. 270, 958-965.
19. Kapfhammer, J. P. (1997). Restriction of plastic fiber growth after lesions by central nervous system myelin-associated neurite growth inhibitors. Adv. Neurol. 73, 7-27.
20. Landolt, R. M., Vaughan, L., Winterhalter, K. H. and Zimmermann, D. R. (1995). Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 121, 2303-2312.
21. LeBaron, R. G., Zimmermann, D. R. and Ruoslahti, E. (1992). Hyaluronate binding properties of versican. J. Biol. Chem. 267, 10003-10010.
22. Zimmermann, D. R. and Ruoslahti, E. (1989). Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 8, 2975-2981.